
Nexiflow D 0.4mg/0.5mg Tablet MR
Marketer
Nexina Life Sciences Pvt Ltd
Salt Composition
Tamsulosin (0.4mg) + Dutasteride (0.5mg)
Overview Nexiflow D 0.4mg/0.5mg Tablet MR
Prostaduo 0.4mg/0.5mg modified-release tablets combine two active ingredients to alleviate symptoms of benign prostatic hyperplasia (BPH) in adult males. This dual-action medication offers relief from urinary frequency and difficulty, but it does not prevent prostate cancer. Prostaduo should be taken consistently at the same time daily, with or without food, as prescribed by your physician. Consistent use is crucial for optimal symptom management; don't skip doses, even if feeling well. While symptom improvement may take up to four weeks, continued use is vital. Report any lack of improvement or worsening symptoms after four weeks to your doctor. Common side effects include erectile dysfunction, reduced libido, chest discomfort, and ejaculatory problems. Contact your doctor if these persist or are concerning. Dizziness or drowsiness may also occur, particularly when starting treatment. Remember, your doctor prescribed this medication because its benefits outweigh potential risks. Prostaduo 0.4mg/0.5mg modified-release tablets are not intended for use by women or children. Inform your doctor about any pre-existing conditions, including low blood pressure, liver or kidney impairment, before commencing treatment, as this medication may be unsuitable. It can interact with other medications; therefore, disclose all current medications to your doctor. Condom use during sexual intercourse is advised if your partner is, or may be, pregnant. Regular blood pressure monitoring may be recommended. Alcohol consumption should be avoided due to the increased risk of dizziness.
Uses of Nexiflow D 0.4mg/0.5mg Tablet MR
Managing benign prostatic hyperplasia
Major Benefits of Nexiflow D 0.4mg/0.5mg Tablet MR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Nexiflow D 0.4mg/0.5mg Tablet MR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistency in timing is recommended.
Common Side effects of Nexiflow D 0.4mg/0.5mg Tablet MR:
- Impotence
- Decreased libido
- Ejaculation disorder
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breast enlargement in male
- Breast tenderness in male
- Dizziness
How to use Nexiflow D 0.4mg/0.5mg Tablet MR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nexiflow D 0.4mg/0.5mg Modified-Release Tablets can be consumed with or without food, though consistent daily timing is recommended.
How Nexiflow D 0.4mg/0.5mg Tablet MR works:
Nexiflow D 0.4mg/0.5mg Modified-Release tablets combine tamsulosin and dutasteride to alleviate benign prostatic hyperplasia symptoms. Tamsulosin, an alpha-adrenergic blocker, eases urine flow by relaxing bladder neck and prostate muscles. Dutasteride, a 5-alpha-reductase inhibitor, reduces prostate size by lowering levels of a hormone that stimulates prostate growth.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Nexiflow D 0.4mg/0.5mg modified-release tablets and alcohol can lead to heightened somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on Nexiflow D 0.4mg/0.5mg MR Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Nexiflow D 0.4mg/0.5mg MR tablets with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, blurred vision, or dizziness after taking Nexiflow D 0.4mg/0.5mg MR tablets, as these side effects may impair alertness.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Nexiflow D 0.4mg/0.5mg MR tablets to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Nexiflow D 0.4mg/0.5mg MR tablets cautiously, potentially requiring a modified dosage. Medical advice is necessary. Nexiflow D 0.4mg/0.5mg MR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Nexiflow D 0.4mg/0.5mg Tablet MR :
Should you forget a Nexiflow D 0.4mg/0.5mg MR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nexiflow D 0.4mg/0.5mg Tablet MR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Urological Care |
